ACHL

ACHL


A Closer Look at PAH Diagnosis, Screening, and Risk Assessment

In this short “How I Do It” vlog, expert faculty Dr. John Ryan, Director, Pulmonary Hypertension Comprehensive Care Center, University of Utah Hospital showcases personal experiences incorporating updated recommendations in clinical practice as well as diagnostic approaches, screening methods, and the importance of risk assessment. Upon completion of this activity, clinicians will be better ...
ACHL

A Next Generation of Pneumococcal Disease Protection

In this modular video-based activity, multidisciplinary faculty provide their perspectives on the changing epidemiology of pneumococcal disease and the protection afforded by a next generation of conjugate vaccines. Hear expert insights on considerations for next generation pneumococcal vaccine use, patient access to these newer vaccines, and strategies for engaging patients. Two case studies dr...
ACHL

Answering the Call: Nurse-Led Strategies to Improve Compliance with Hemophilia Prophylaxis

Prophylactic management of hemophilia continues to be a challenge. The nurse-led activity discusses treatment strategies, safety and efficacy of current available products, and how to improve patient adherence. In this clinical commentary Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C review best practices to facilitate successful therapeutic interventions with hemophilia A Kerry H. Hanse...
ACHL

Beyond the Procedure: Evolving the Current Standard of Care for Patients with PAD

In three fast-paced modules, a multispecialty panel of cardiology, radiology, and vascular surgery experts provide perspectives on preventing adverse limb events in patients undergoing revascularization. Vascular medicine expert Dr. Anahita Dua moderates these brief discussions and case presentations with a focus on the latest clinical trial data and implications for patient care.
ACHL

Case Challenges in Patients With EGFR-Mutant NSCLC

This activity offers a case challenge of two patients with EGFR-mutant NSCLC, through which learners apply knowledge from the molecular testing guidelines and evidence from clinical trials as presented in the related activity, Identifying Actionable Markers to Guide Therapy for Patients With EGFR-Mutant NSCLC. Learners work through patient cases during which they are questioned about how they wo...
ACHL

Checkpoint Blockade in the Adjuvant and Neoadjuvant Settings: Key Considerations for the Surgical Oncologist

A multidisciplinary panel of faculty discuss the use of neoadjuvant and adjuvant immunotherapy for esophageal and gastric cancers in this recorded virtual tumor board. Throughout the case discussions, faculty discuss how to properly incorporate immunotherapies into care plans based on the latest clinical trial data and recommendations. The faculty also highlight the role of biomarkers in identif...
Society of Surgical Oncology (SSO)

Complex Chronic Deep Venous Disease: A Multidisciplinary Discussion

Are you confident with managing cases of complex chronic deep venous disease? This 30-minute roundtable discussion, features leading venous disease experts, Minhaj Khaja, MD, MBA, FSIR from University of Virginia; Andrea Obi, MD from University of Michigan; and Aditya Sharma, MD, from University of Virginia who highlight complex cases related to chronic deep venous disease. Faculty discuss the l...
ACHL

Considerations for Antimicrobial Selection in Clostridioides difficile Infection

This educational program is designed for infectious disease pharmacists interested in new therapies and clinical trials in the treatment of CDI. Dr. Paul Feuerstadt and Dr. Kevin Garey discuss community and healthcare-associated infections, recent updates to guidelines, and evidence-based selection of antimicrobial therapy for the treatment of initial infection and prevention of recurrence. W...
ACHL

Differentiating Early Signs of Alzheimer Disease From Normal Signs of Aging and Determining Best Next Steps.

Join us for this in-depth look at the early diagnosis of Alzheimer disease. Dr. James Galvin presents ways to differentiate Alzheimer disease from other neurodegenerative disorders, implement appropriate testing methods for earlier detection, and apply recent evidence to treatment selection to optimize patient outcomes.
ACHL

DOACs in Transition: Examining the Challenges and Complexity of Transitions in Care

Why should hospitalists, cardiologists, and other clinicians care about optimal post-discharge prophylaxis in patients with acute medical illness? What strategies are available to better ensure optimal post-discharge prophylaxis in this patient population? This clinical commentary features leading thrombosis expert, Dr. Alex Spyropoulos, and a multidisciplinary panel, covering these important qu...
ACHL

From Risk Assessment to Treatment: Real-World Approaches to PAH

In this clinical commentary, join cardiology expert Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan and pulmonology expert Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center as they provide real-world advice on the management of pulmonary arterial hypertension (PAH). These experts will discuss thei...
ACHL

Hard to Swallow: Bridging Knowledge Gaps in Eosinophilic Esophagitis

Did you know that the incidence of eosinophilic esophagitis (EoE) is increasing rapidly? Are you familiar with the burdens faced by adult and pediatric patients living with EoE? In this multi-module activity led by an interdisciplinary panel, access practical guidance and supplemental resources on the management and treatment of EoE. Navigate at your own pace through video modules and an interac...
ACHL

Highlights from Kidney Week

Expert faculty, Dr. Jai Radhakrishnan explores clinical trial data coming out of ASN 2021, and provides learners with up-to-date knowledge on focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN). This brief interview-style video offers insights into the patient burden of chronic kidney disease, advances in understanding the pathophysiology, and emerging approaches to treatment fo...
ACHL

Highlights from the 12th Annual Linda Morgante MS Nurse Leadership Program

This enduring activity features three presentations from the 12th Annual Linda Morgante MS Nurse Leadership Program held virtually on June 26, 2021. These presentations will provide multiple sclerosis (MS) nurses access to the latest evidence and strategies related to treatment selection, treat-to-target approaches, and symptom management as part of comprehensive patient care to improve outcomes.
ACHL

Hot Topics in Oncology – Focus on the Immune Checkpoint Inhibitors (ICIs)

The immune checkpoint inhibitors (ICIs) continue to break ground in a multitude of cancer types. With ever-evolving data and recommendations, oncology clinicians must keep pace with the latest ICI updates. This recorded CME-certified session tackles questions surrounding topics related to immune checkpoint inhibitors with discussion on: • Role of biomarkers with ICI selection and monitorin...
ACHL

Hot Topics in PAH: What We’ve Learned in the Past Year

How can clinicians improve early detection of PAH? What are some practical strategies for managing PAH patients in today’s world? What recent data support current treatment strategies, and what are emerging therapeutic options? This 30-minute multimedia Q&A touchpoint “Hot Topics” CME activity features leading pulmonology expert Dan Schuller, MD, from Texas Tech University Health Sciences ...
ACHL

Identifying Actionable Markers to Guide Therapy for Patients With EGFR-Mutant NSCLC

This interactive digital activity combines animated slides and expert video commentary on molecular testing recommendations, guidance on interpreting molecular testing results, and clinical trial evidence to enhance the implementation of precision medicine in the care of patients with EGFR-mutant NSCLC. Through this education, learners explore best practices for EGFR mutation testing, applicatio...
ACHL

Improving Outcomes in Chronic Limb-threatening Ischemia: Practical Approaches to Above- and Below-the-knee Interventions

In this targeted 45-minute CME touchpoint, Dr. Anahita Dua, vascular surgeon from Massachusetts General Hospital, and Dr. Mitchell Weinberg from Staten Island University Hospital and Zucker School of Medicine at Hofstra/Northwell, discuss the latest updates in approaches to above-the-knee and below-the-knee interventions for chronic limb-threatening ischemia (CLTI). The faculty will also address...
ACHL

Improving the Prognosis for Patients with BRAF-Mutant and/or MSI-H mCRC

Are you current with the latest updates with MSI-H/dMMR and/or BRAF-mutant metastatic colorectal cancer? In this case-based activity, leading expert and researcher, Dr. Dung Le discusses the latest approvals and recommendations for patients with MSI-H/dMMR and/or BRAF-mutant mCRC. This activity also features interactive case presentations which involve biomarker testing, treatment selection, and...
ACHL

Individualizing Prostate Cancer Treatment: Special Considerations for Gay and Bisexual Men

This activity features a panel consisting of an oncologist and leading experts (a urologist and a researcher) in prostate cancer care considerations in gay and bisexual men (GBM), where they discuss quality of life considerations and disparities. The panel’s aim is to provide clinicians with real-world strategies to facilitate optimal communication and shared decision-making with these patient...
ACHL

Late-breaking Science with DOACs and Implications for Patient Care

Hear from Christian Ruff, MD, MPH on the latest clinical trial data related to DOACs and implications for patient care. This expert perspective provides clinicians with practical insights to apply to their practice. Dr. Ruff discusses the most recent evidence with DOACs across a multitude of disease states, including acute venous thromboembolism in patients with elevated BMI, peripheral artery d...
ACHL

Latest Data in FSGS and IgAN

Expert faculty, Dr. Richard Lafayette, explores clinical trial data coming out of a recent nephrology meeting, and provides learners with up-to-date knowledge on focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN). This brief interview-style video offers insights into the patient burden of chronic kidney disease, advances in understanding the pathophysiology, and emerging approa...
ACHL

Matching Treatment to Mutations: Clinical Pathways to Optimize RET+ Testing in NSCLC and Thyroid Cancer

This recording from a series of expert-led small group meet-ups will increase your knowledge of RET inhibitors, help you gain confidence in utilizing biomarkers to inform treatment decisions, and improve collaboration between oncologists and pathologists to optimize precision medicine for RET-positive metastatic NSCLC and advanced thyroid cancer.
Penn State College of Medicine

Matching Treatment to Mutations: Clinical Pathways to Optimize RET+ Testing in NSCLC and Thyroid Cancer

Join the discussion! We bring the expert to you. LIVE. VIRTUAL. FLEXIBLE. Interactive discussion on optimization of RET+ testing in NSCLC and thyroid cancer, and the pathways for enhancing collaboration between pathologists and oncologists to improve patient care. Choose a date that works best with your schedule! Your questions answered on precision medicine! - What are the roles of biomar...
ACHL

Menopause Matters…Let’s Start Paying Attention to Racial and Ethnic Differences.

This activity addresses disparities in the treatment of vasomotor symptoms faced by menopausal women of diverse racial and ethnic backgrounds. Faculty discussion covers overcoming these disparities, guideline recommendations, a novel mechanism for controlling vasomotor symptoms, and strategies to educate patients. First-hand patient testimonials complement the discussion.
ACHL

Multidisciplinary Viewpoints on NTM-LD Diagnosis and Management

In two virtual roundtables, a pulmonologist, infectious disease specialist, and clinical pharmacist share their experiences in addressing challenges in diagnosing and treating patients with NTM-LD. The expert panel discusses strategies for expediting diagnosis and improving patient care and outcomes within the context of a patient’s reflections on the path to diagnosis and their treatment expe...
ACHL

On a Limb: How Can We Better Optimize PAD Care?

Are your patients with PAD post-revascularization “on a limb”? Find out as Marc Bonaca, MD, MPH covers the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. This expert perspective provides clinicians with practical insights to apply to their practice. The purpose of this activity is to provide learners with an engaging,...
ACHL

Oral Combination Therapy: The PAtH to Improved Patient Care in PAH

Are you interested in finding out how you can more effectively manage your patients with PAH? In this short “How I Do It” vlog, expert faculty Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan discusses recommendations for the use of oral combination therapies in PAH along with her experiences and considerations with these treatment options...
ACHL

PAH and COVID-19: A Patient’s Journey

PAH patient and advocate, Jen C., shares her perspective, experience, and challenges with managing her PAH every day and during her COVID-19 infection. Learn from her journey and consider how her experiences may improve your own PAH patients’ outcomes.
ACHL

Pathways to Transfusion Independence & Reduced Health Complications: Advances for Lower-Risk MDS

In this dynamic case challenge format, expert faculty work through two patient cases and offer supporting data and practical experience to establish optimal recognition, diagnostic, and treatment practices, and discuss opportunities for shared decision making with patients. Learners are questioned about how they would proceed at different clinical decision points, and faculty commentaries offer ...
ACHL

PFF Summit Highlights: News You Can Use

Across three brief videos, expert faculty Dr. Joseph Lasky discusses highlights and data from the PFF Summit 2021, which took place virtually. Dr. Lasky provides insights into updated diagnostic guidance, emerging therapies, and patient perspectives across the spectrum of interstitial lung diseases (ILD). Don’t miss this opportunity to hear the latest research in ILD! A differential diagnos...
ACHL

Postdischarge Thromboprophylaxis for Acutely Ill Medical Patients

Did you know that hospitalized acutely ill medical patients remain at risk for venous thromboembolism (VTE) well past the time of discharge? In this short vlog, learn how to identify risk factors and avoid this complication as Dr. Mark Goldin shares a hospitalist’s perspective on the latest updates on postdischarge VTE prophylaxis for acutely ill medical patients. Dr. Goldin also discusses inn...
ACHL

Practical Considerations for Patients with PAD Post-Revascularization

This vlog provides learners with the perspective of a leading vascular medicine expert, Dr. Anahita Dua, on recent advances and practical considerations for patients with PAD post-revascularization. Talking points include the latest approvals and evidence, real-world implications of these recent advances, and roles of the interdisciplinary team in the management of this patient population. Th...
ACHL

Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2

Host a complimentary Virtual Visiting Professorship Program (VPP): Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2. Easy-to-administer one-hour complimentary virtual independent medical education is available to your institution. We will coordinate a day and time that works for your intuition and bring the expert to ...
ACHL

Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2

Are you involved in treating patients with triple negative breast cancer (TNBC)? The emergence of TROP2-directed antibody drug conjugate (ADC) technology has paved the way for exciting new targeted treatment approaches for patients with TNBC. What are the latest data with these ADCs? Why is TROP2 an effective target in TNBC? How do we best incorporate these TROP2-targeted ADCs into TNBC care...
Rush University Medical Center

Practical Tools & Expert Guidance for the Nurse Navigator and Clinical Team: Strategies to Reduce Treatment Disparities in Multiple Myeloma

This immersive practice guide offers a “how to” method for introducing day-to-day strategies in the real world through data, guidelines, and decision-making recommendations. Expert faculty address which approaches may not be working, complexities in managing this patient population, insights on how the latest evidence supports a practical recommendation and review available therapies to opti...
ACHL

Precision Medicine for All: Strategies for Meaningful and Sustainable Improvements to Reduce Health Disparities in NSCLC

Despite the advances in precision medicine for non-small cell lung cancer (NSCLC), a significant proportion of patients, particularly African American and Hispanic patients, face inequities with access to these health breakthroughs. In this activity, expert faculty focus on the latest evidence with NSCLC disparities of care and how to best overcome these barriers. The activity also reviews how t...
Rush University Medical Center

RCC Treatment Strategies in a Favorable-Risk Patient

Immune checkpoint inhibitor/tyrosine kinase inhibitor combination therapy has forged to the front-line for the management of metastatic RCC and recurrent RCC, but how do clinicians select the ideal treatment regimen for their patients? How does patient risk status influence the decision-making process? This virtual tumor board features a multidisciplinary expert panel presenting a favorable-risk...
ACHL

RCC Treatment Strategies in a Poor-Risk Patient

Did you know that the current 5-year survival rate for patients diagnosed with metastatic RCC is only 12% despite advances in molecular research over the past decade? Are you familiar with recent treatment guidelines and clinical trial data showcasing the benefits of treating poor- and intermediate-risk ccRCC patients with immuno-oncology/tyrosine kinase inhibitor combination therapy? This virtu...
ACHL

Real-World Experience in Diagnosing and Managing PNH in Special Patient Populations

In a “how I do it” clinical commentary, Dr. Jamile Shammo and Dr. Ilene Weitz share their real-world experience in the diagnosis and management of PNH in special patient populations. This case-based activity includes clinical scenarios and treatment strategies to improve patient outcomes.
ACHL

Real-World Perspectives on the Role of TYK2 Inhibitors in the Treatment of Psoriasis

How are TYK2 inhibitors different from conventional JAK inhibitors? In what patient population would they be best suited? Find out in this expert-led clinical review and panel discussion that provides the knowledge you need on the investigational TYK2 inhibitors and their potential roles in personalized psoriasis treatment plans. This content is available across two modules, allowing you to cho...
ACHL

Reducing Healthcare Disparities for PAH Patients

Very few studies have assessed the impact of healthcare disparities on PAH, despite the potential adverse impacts. One such study from Talwar et al reported that minority PAH patients may be at risk for worse outcomes due to lack of healthcare access, insurance gaps, and socioeconomic status. Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center, draws f...
ACHL

Spotlight on IRON CLAD: Clinical Review of IV Iron Replacement Therapy for Cancer-and Chemotherapy-Induced Anemia

This quick, comprehensive video will review the diagnosis and treatment of cancer- and chemotherapy-induced anemia (CIA). Expert faculty, Dr. Jeffrey Gilreath from University of Utah Hospitals and Clinics will discusses the role of intravenous (IV) iron replacement monotherapy, including ferric carboxymaltose (FCM), recent clinical trial data supporting its benefit in treatment of CIA, and mana...
ACHL

T2D Management in Primary Care Practice: Addressing the Weight of it All

This expert-led activity offers a “how to” method for introducing strategies that support management of both dysglycemia and obesity. This activity highlights the ramifications of untreated obesity in patients with dysglycemia to underscore the importance of early obesity intervention. It also outlines ways to individualize obesity and dysglycemia management, recognize the benefits of earlie...
ACHL

Treatment Considerations for PAH Patients During the Pandemic

Are you taking the right precautions to ensure your patients with PAH are safely managed during COVID-19? Are you employing effective therapeutic management strategies with your PAH patients during the pandemic? In this short CME-certified vlog, leading pulmonologist Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center, discusses how to effectively mana...
ACHL

Tryptase Testing in Chronic Mast Cell Disorders and Acute Settings

Are you familiar with the role of serum tryptase testing in diagnosing idiopathic anaphylaxis and mastocytosis? What role does serum tryptase play in the ongoing management of patients who have anaphylactic reactions to insect venom, and are there different considerations when a patient has a known trigger? Expert faculty Dr. Phil Lieberman shares his insights on serum tryptase testing in clinic...
ACHL

Tryptase Testing: Clinical Utility and Application During COVID-19 Vaccination Reactions

What is the risk of anaphylaxis following vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19)? Are you familiar with the role of serum tryptase testing in patients with a suspected anaphylactic reaction? Expert faculty, Dr. Cem Akin, discusses serum tryptase testing and its importance in assessing anaphylaxis in response to COVID-19 vaccination. This moder...
ACHL

What Every Clinician Needs to Know About COVID-19 and Thrombosis

As the COVID-19 pandemic continues to wage on, are you prepared to prevent and treat your patients for COVID-19-related venous thromboembolism (VTE)? In this short vlog, learn how to develop appropriate regimens with antithrombotic therapy for this patient population and hear about the promising PREVENT-HD trial. Leading VTE expert, Dr. Gregory Piazza, outlines key real-world insights that you ...
ACHL

Who’s On The Tightrope? Understanding Patients With Chronic Polyvascular Disease

Many atherosclerotic cardiovascular disease (ASCVD) patients do well after suffering a heart attack or stroke, but frequently, these patients continue to be at high risk for recurrent cardiovascular events and are not necessarily stable. It is important to understand the patients, particularly those with polyvascular disease, at higher risk for recurrent events. Are you current with how to best ...
ACHL

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map